Allogeneic Cord Blood Cells for Adults With Severe Acute Contusion Spinal Cord Injury
Allogeneic Mononuclear Umbilical Cord Blood Systemic Infusions for Adult Patients With Severe Acute Contusion Spinal Cord Injury: Phase I Safety Study and Phase IIa Primary Efficiency Study
Sponsor: National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
Listed as NCT04331405, this PHASE1/PHASE2 trial focuses on Spinal Cord Contusion and remains completed. Sponsored by National Medical Research Center for Cardiology, Ministry of Health of Russian Federation, it has been updated 5 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE1/PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE1_PHASE2
-
May 2020 — Jan 2021 [monthly]
Completed PHASE1_PHASE2
First recorded
Mar 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
- Sklifosovsky Institute of Emergency Care
For direct contact, visit the study record on ClinicalTrials.gov .